Today a biotech stock of Aptorum (NASDAQ: APM) soars more than 1100% in premarket after announcing the launching of its startup along with Singaporean-based Accelerate Technologies. The subsidiary of the company will handle infectious disease liquid biopsy issues and now co-working to develop molecular-based rapid pathogen diagnostics technology to track pathogenic genome.
With good news, the stock gains enormous points but within a month APM might lose significantly unless other news comes out from its media. Usually, long term investors win in this case as they do not even plan to get the cosmic returns while their intentions are purely based on dividends.
Let’s wait what happens to the APM shares after the market close. Perhaps, the stock will firmly stand at $4.00 as speculators sell most of their long time earning shares seeing the instant price jump.
Editor and Computer Expert
A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.